Pharmaceuticals UK

UK Lupus Treatment Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

UK Lupus Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UK · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $68.3 Mn Placeholder estimate
Estimate 2025 $73.5 Mn 2.2% of the global market
Projected 2034 $142.1 Mn 93.3% Adds $68.6 Mn over 9 forecast years
CAGR 2025–2034 7.6% Faster than 59% of 180 Pharmaceuticals markets here
Key players 5
  • UK is 2.17% of the global market.
  • In Europe, the largest is Germany at $121.2 Mn.
  • Fastest growing: Russia at 10% a year.
  • UK ranks 4th of 6 by size in Europe.

Market size projection

UK

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$68.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Lupus Treatment Market market size by year, UK
YearMarket sizeChange that yearSince 2025
2024 (estimate) $68.3 Mn — —
2025 (base) $73.5 Mn +$5.2 Mn —
2026 (forecast) $79.1 Mn +$5.6 Mn +7.6%
2027 (forecast) $85.1 Mn +$6.0 Mn +15.8%
2028 (forecast) $91.6 Mn +$6.5 Mn +24.6%
2029 (forecast) $98.5 Mn +$7.0 Mn +34%
2030 (forecast) $106.0 Mn +$7.5 Mn +44.2%
2031 (forecast) $114.1 Mn +$8.1 Mn +55.2%
2032 (forecast) $122.8 Mn +$8.7 Mn +67%
2033 (forecast) $132.1 Mn +$9.3 Mn +79.7%
2034 (forecast) $142.1 Mn +$10.0 Mn +93.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $3.39 Bn
  2. US $1.53 Bn
  3. North America $1.49 Bn
  4. APAC $792.6 Mn
  5. Europe $583.4 Mn
  6. China $309.8 Mn
  7. Canada $239.1 Mn
  8. Japan $196.5 Mn
  9. Middle East $146.2 Mn
  10. Latin America $133.9 Mn
  11. Germany $121.2 Mn
  12. France $88.9 Mn
  13. Italy $88.3 Mn
  14. Brazil $89.9 Mn
  15. UK (this report) $73.5 Mn
  16. India $73.7 Mn
  17. Spain $66.3 Mn
  18. Saudi Arabia $66.8 Mn
  19. Ecuador $62.9 Mn
  20. Africa $58.2 Mn
  21. Mexico $52.1 Mn
  22. Russia $40.2 Mn
  23. Australia $40.8 Mn
  24. New Zealand $36.2 Mn
  25. South Africa $24.9 Mn
  26. UAE $16.5 Mn
  27. Egypt $9.2 Mn
  28. Philippines $6.6 Mn
  29. Hong Kong $5.5 Mn
  30. Malaysia $5.4 Mn
  31. Thailand $3.8 Mn
  32. Singapore $3.5 Mn
  33. Kenya $2.6 Mn

Report snapshot

UK Lupus Treatment Market Analysis at a glance
Market size, 2025$73.5 Mn placeholder estimate
Forecast, 2034$142.1 Mn placeholder estimate
Growth (CAGR), 2025–20347.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDrug class, type and end user (see all)
Key playersGSK PLC, AstraZeneca, Aurinia Pharmaceuticals, Roche, Novartis AG (see all)
Regulator in the UKMHRASource: Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
Active clinical trials39 in the UKSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the UK. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UK Lupus Treatment Market Analysis Executive Summary

Lupus treatments calm an autoimmune disease that can affect the skin, joints, kidneys and other organs.

Key segments of the lupus Treatment market include drug class (Antimalarials, Corticosteroids and Biologics) and type (Systemic Lupus Erythematosus, Lupus Nephritis and Cutaneous Lupus).

Bar chart: UK Lupus Treatment market size, 2024–2034, placeholder estimates. $68.3 Mn in 2024, $73.5 Mn in 2025 and $142.1 Mn in 2034, 7.6% CAGR.
UK Lupus Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UK Lupus Treatment Market Dynamics

Market Growth Drivers

More people diagnosed with immune diseases, strong results from biologics and oral targeted drugs, and earlier treatment are driving the lupus Treatment market. Biosimilars are widening access.

Opportunity

New targets, oral drugs that replace injections and cell therapies for autoimmune disease give the lupus Treatment market room to grow.

Market Restraints

High prices, infection risks with immune-suppressing drugs, patent expiries and the need for long-term treatment hold back the lupus Treatment market.

Competitive Landscape for Lupus Treatment Market in UK

The lupus Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Lupus Treatment Market in UK

Lupus Treatment in the UK: rules, payment and research

The Medicines and Healthcare products Regulatory Agency (MHRA) licenses medicines in the UK.⁠[1] The NHS gives care that is free at the point of use; in England, NICE advises which medicines and treatments the NHS should fund.⁠[2] ClinicalTrials.gov lists 39 studies on Lupus Treatment that are recruiting, active or about to start in the UK.⁠[3]

[1] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[2] National Institute for Health and Care Excellence. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the UK. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for lupus Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in UK.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Lupus Treatment right now, from free public sources.

Clinical trials

39 active trials in the UK

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. AstraZeneca 25 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Bristol-Myers Squibb 10 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Novartis AG 9 active trials on ClinicalTrials.gov (opens in a new tab)
  4. China Immunotech (Beijing) Biotechnology Co., Ltd. 6 active trials on ClinicalTrials.gov (opens in a new tab)
  5. GSK PLC 5 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 30 papers since 2021 (worldwide)

  1. Restoring B cell intrinsic tolerance to lupus autoimmunity: a rational strategy for lupus treatment. Frontiers in immunology, 2026
  2. Optimizing Hydroxychloroquine in Lupus Treatment: Looking Beyond the 5-mg/kg Weight-Based Dosing Cutoff. Arthritis & rheumatology (Hoboken, N.J.), 2026
  3. NICE approves lupus treatment that restores kidney function. BMJ (Clinical research ed.), 2026
  4. Adductome-based identification of lysine monomethylation as a key post-translational protein modification in autoimmune diseases. The Journal of biological chemistry, 2025
  5. Hypertension, proteinuria, and RAAS inhibition use in children with systemic lupus erythematosus: Data from a multi-institutional pediatric learning health system. Lupus, 2025
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Lupus Treatment in context

The UK compared

  • Health spending per person: 5,860 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 6 countries we cover in Europe.[1]
  • Doctors: 3.30 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 5th highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 19.7% of people (2025). World: 10.4% of people (2025). 5th highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Lupus Treatment market in the UK?
Placeholder estimate: about $73.5 Mn in 2025, rising to about $142.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Lupus Treatment market in the UK growing?
Placeholder estimate: about 7.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Lupus Treatment market report cover?
The report splits the market by drug class (Antimalarials, Corticosteroids, Biologics, Immunosuppressants and more), type (Systemic Lupus Erythematosus, Lupus Nephritis, Cutaneous Lupus) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Lupus Treatment market?
Key players include GSK PLC, AstraZeneca, Aurinia Pharmaceuticals, Roche and Novartis AG.
What is driving the Lupus Treatment market?
More people diagnosed with immune diseases, strong results from biologics and oral targeted drugs, and earlier treatment are driving the lupus Treatment market. Biosimilars are widening access.
Who regulates Lupus Treatment in the UK?
The Medicines and Healthcare products Regulatory Agency (MHRA) licenses medicines in the UK. Source: Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
How is healthcare paid for in the UK?
The NHS gives care that is free at the point of use; in England, NICE advises which medicines and treatments the NHS should fund. Source: National Institute for Health and Care Excellence. Checked 14 Nov 2026.
How many clinical trials on Lupus Treatment are running in the UK?
39 studies are recruiting, active or about to start in the UK, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the UK. Retrieved 12 Nov 2026.
How much research is published on Lupus Treatment?
PubMed lists 30 papers on Lupus Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Lupus Treatment in UK? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Patient Support Programmes: Helping Patients Stay on TreatmentWHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient… Biologic Safety Testing: The Quiet Backbone of Drug MakingEvery vaccine, antibody and cell therapy must be tested for sterility, purity and viruses before it reaches… Cell-Based Immunotherapy: Promise and PriceThe first CAR-T cell therapy was approved in the US in August 2017. These living drugs can work when other…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in UK

See all
Same topic, other categories

Related on autoimmune diseases and biologics and biosimilars

See the topic